Literature DB >> 12496080

Conformational partitioning of the fusion peptide of HIV-1 gp41 and its structural analogs in bilayer membranes.

Michael W Maddox1, Marjorie L Longo.   

Abstract

Experiments have shown that the ability of the HIV-1 virus to infect cells can be greatly diminished by deactivation of the N-terminal (fusion) peptide of its glycoprotein gp41. Deactivation can be achieved by the deletion of several amino acid residues, or replacement of a hydrophobic residue with a polar residue, to form mutant variants of the wild-type peptide. We report Monte Carlo simulation studies of a simplified peptide/membrane model, representing the interaction of an HIV-1 fusion peptide (FP) and four closely related mutagens with a lipid bilayer. In agreement with experimental results, we show that FP inserts deeply into the bilayer at approximately 40 degrees to the bilayer normal. We also show a previously unreported behavior of membrane peptides, namely their equilibrium partitioning between several distinct conformations within the bilayer. We quantify this partitioning behavior and characterize each conformation in terms of its geometry, energy, and entropy. The diminished ability of FP mutagens to hemolyse and aggregate red blood cells due to their partitioning into unfavorable conformations, is also discussed. Our analysis supports a negative curvature mechanism for red blood cell hemolysis by FP. We also suggest that the small repulsive forces between surface-adsorbed peptides in opposing membrane surfaces may block aggregation.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12496080      PMCID: PMC1302388          DOI: 10.1016/S0006-3495(02)75313-7

Source DB:  PubMed          Journal:  Biophys J        ISSN: 0006-3495            Impact factor:   4.033


  18 in total

Review 1.  Modulation of membrane curvature by peptides.

Authors:  R M Epand; R F Epand
Journal:  Biopolymers       Date:  2000       Impact factor: 2.505

2.  A Monte Carlo study of peptide insertion into lipid bilayers: equilibrium conformations and insertion mechanisms.

Authors:  Michael W Maddox; Marjorie L Longo
Journal:  Biophys J       Date:  2002-01       Impact factor: 4.033

3.  Membrane interactions of the synthetic N-terminal peptide of HIV-1 gp41 and its structural analogs.

Authors:  P W Mobley; A J Waring; M A Sherman; L M Gordon
Journal:  Biochim Biophys Acta       Date:  1999-04-14

4.  A mutation in the human immunodeficiency virus type 1 transmembrane glycoprotein gp41 dominantly interferes with fusion and infectivity.

Authors:  E O Freed; E L Delwart; G L Buchschacher; A T Panganiban
Journal:  Proc Natl Acad Sci U S A       Date:  1992-01-01       Impact factor: 11.205

5.  Characterization of the fusion domain of the human immunodeficiency virus type 1 envelope glycoprotein gp41.

Authors:  E O Freed; D J Myers; R Risser
Journal:  Proc Natl Acad Sci U S A       Date:  1990-06       Impact factor: 11.205

6.  A syncytia assay for human immunodeficiency virus type I (HIV-I) envelope protein and its use in studying HIV-I mutations.

Authors:  J M Felser; T Klimkait; J Silver
Journal:  Virology       Date:  1989-06       Impact factor: 3.616

7.  Hydrophilicity of polar amino acid side-chains is markedly reduced by flanking peptide bonds.

Authors:  M A Roseman
Journal:  J Mol Biol       Date:  1988-04-05       Impact factor: 5.469

8.  Shape of the hydrophobic barrier of phospholipid bilayers (evidence for water penetration in biological membranes).

Authors:  O H Griffith; P J Dehlinger; S P Van
Journal:  J Membr Biol       Date:  1974       Impact factor: 1.843

9.  Orientation into the lipid bilayer of an asymmetric amphipathic helical peptide located at the N-terminus of viral fusion proteins.

Authors:  R Brasseur; M Vandenbranden; B Cornet; A Burny; J M Ruysschaert
Journal:  Biochim Biophys Acta       Date:  1990-11-16

10.  The polar region consecutive to the HIV fusion peptide participates in membrane fusion.

Authors:  S G Peisajovich; R F Epand; M Pritsker; Y Shai; R M Epand
Journal:  Biochemistry       Date:  2000-02-22       Impact factor: 3.162

View more
  14 in total

1.  Irregular structure of the HIV fusion peptide in membranes demonstrated by solid-state NMR and MD simulations.

Authors:  Dorit Grasnick; Ulrich Sternberg; Erik Strandberg; Parvesh Wadhwani; Anne S Ulrich
Journal:  Eur Biophys J       Date:  2011-01-28       Impact factor: 1.733

2.  A strong correlation between fusogenicity and membrane insertion depth of the HIV fusion peptide.

Authors:  Wei Qiang; Yan Sun; David P Weliky
Journal:  Proc Natl Acad Sci U S A       Date:  2009-08-24       Impact factor: 11.205

3.  Solid-state nuclear magnetic resonance measurements of HIV fusion peptide 13CO to lipid 31P proximities support similar partially inserted membrane locations of the α helical and β sheet peptide structures.

Authors:  Charles M Gabrys; Wei Qiang; Yan Sun; Li Xie; Scott D Schmick; David P Weliky
Journal:  J Phys Chem A       Date:  2013-02-28       Impact factor: 2.781

4.  Conformational flexibility and strand arrangements of the membrane-associated HIV fusion peptide trimer probed by solid-state NMR spectroscopy.

Authors:  Zhaoxiong Zheng; Rong Yang; Michele L Bodner; David P Weliky
Journal:  Biochemistry       Date:  2006-10-31       Impact factor: 3.162

5.  Interfacial folding and membrane insertion of designed peptides studied by molecular dynamics simulations.

Authors:  Wonpil Im; Charles L Brooks
Journal:  Proc Natl Acad Sci U S A       Date:  2005-04-28       Impact factor: 11.205

6.  HIV fusion peptide penetrates, disorders, and softens T-cell membrane mimics.

Authors:  Stephanie Tristram-Nagle; Rob Chan; Edgar Kooijman; Pradeep Uppamoochikkal; Wei Qiang; David P Weliky; John F Nagle
Journal:  J Mol Biol       Date:  2010-07-22       Impact factor: 5.469

7.  HIV fusion peptide and its cross-linked oligomers: efficient syntheses, significance of the trimer in fusion activity, correlation of beta strand conformation with membrane cholesterol, and proximity to lipid headgroups.

Authors:  Wei Qiang; David P Weliky
Journal:  Biochemistry       Date:  2009-01-20       Impact factor: 3.162

8.  Oligomeric beta-structure of the membrane-bound HIV-1 fusion peptide formed from soluble monomers.

Authors:  Jun Yang; Mary Prorok; Francis J Castellino; David P Weliky
Journal:  Biophys J       Date:  2004-09       Impact factor: 4.033

9.  Modeling amyloid beta-peptide insertion into lipid bilayers.

Authors:  David L Mobley; Daniel L Cox; Rajiv R P Singh; Michael W Maddox; Marjorie L Longo
Journal:  Biophys J       Date:  2004-06       Impact factor: 4.033

10.  Effect of the HIV-1 fusion peptide on the mechanical properties and leaflet coupling of lipid bilayers.

Authors:  P Shchelokovskyy; S Tristram-Nagle; R Dimova
Journal:  New J Phys       Date:  2011-02       Impact factor: 3.729

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.